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Intrinsically disordered proteinThe Cancer/Testis Antigen (CTA), Prostate-associated Gene 4 (PAGE4), is a stress-response protein that is upreg-
ulated in prostate cancer (PCa) especially in precursor lesions that result from inﬂammatory stress. In cells under
stress, translocation of PAGE4 to mitochondria increases while production of reactive oxygen species decreases.
Furthermore, PAGE4 is also upregulated in human fetal prostate, underscoring its potential role in development.
However, the proteins that interact with PAGE4 and the mechanisms underlying its pleiotropic functions in
prostatic development and disease remain unknown. Here, we identiﬁed c-Jun as a PAGE4 interacting partner.
We show that both PAGE4 and c-Jun are overexpressed in the human fetal prostate; and in cell-based assays,
PAGE4 robustly potentiates c-Jun transactivation. Single-molecule Förster resonance energy transfer experi-
ments indicate that upon binding to c-Jun, PAGE4 undergoes conformational changes. However, no interaction
is observed in presence of BSA or unilamellar vesicles containing the mitochondrial inner membrane
diphosphatidylglycerol lipid marker cardiolipin. Together, our data indicate that PAGE4 speciﬁcally interacts
with c-Jun and that, conformational dynamics may account for its observed pleiotropic functions. To our
knowledge, this is the ﬁrst report demonstrating crosstalk between a CTA and a proto-oncogene. Disrupting
PAGE4/c-Jun interactions using small molecules may represent a novel therapeutic strategy for PCa.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Prostate-associated gene4 (PAGE4) is amember of the Cancer/Testis
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ights reserved.germ cells, is silent in most somatic tissues, but is aberrantly expressed
in several types of cancer [1–3] including prostate cancer (PCa) [4].
PAGE4 is also a developmentally-regulated gene that is upregulated
in the fetal prostate compared to the normal adult gland. Further, in
addition to frank prostate adenocarcinoma lesions, PAGE4 expression
is highly upregulated in proliferative inﬂammatory atrophy (PIA)
(Zeng et al., unpublished) and high-grade prostatic intraepithelial
neoplasia (HG-PIN) lesions [5]. Both PIA and HG-PIN are thought
to result from inﬂammatory stress and represent tumorigenic
precursors [6]. Hence, the dramatic upregulation of PAGE4 in these pre-
cursor lesions strongly suggests that PAGE4 may be a stress-response
protein.
Consistent with a stress-response function, PAGE4 protein levels are
upregulated when PCa cells are treated with various stress factors
including the proinﬂammatory cytokine TNFα. In cells challenged
with stress, there is increased translocation of the PAGE4 protein to
themitochondrion and suppressed reactive oxygen species production.
Furthermore, p21 is elevated in a p53-independent manner in PAGE4
overexpressing cells which results in impeded cell cycle progression,
attenuated stress-induced DNA damage, and decreased cell death (Zeng
et al., unpublished). Thus, overexpression of PAGE4 in the stress-
enriched PCa microenvironment appears to be a protective response to
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the mechanism(s) underlying these pleiotropic functions of PAGE4 in
prostatic development and disease are not fully understood and the
proteins that interact with it remain unidentiﬁed.
One clue to its potential function became apparent whenwe discov-
ered that PAGE4, like the majority of the CTAs, is a highly intrinsically
disordered protein (IDP) [7,8]. In contrast to the prevailing notion that
proteins are highly structured molecules and that structure deﬁnes
function, research over the last 15 years has revealed that a signiﬁcant
fraction of the proteome of organisms across all living kingdoms is
unstructured or intrinsically disordered [9]. Thus, IDPs are proteins that,
under physiological conditions, at least in vitro, lack rigid 3D structures
either along their entire length or in localized regions of the molecule.
Despite the lack of structure, IDPs play important biological roles that
include transcriptional regulation and signaling via protein–protein
interaction networks [10,11].
A comprehensive study of protein interaction networks (PINs) from
yeast to humans revealed that proteins that constitute hubs in a PIN are
signiﬁcantly more disordered compared to proteins that constitute
edges [12,13], underscoring the role of IDPs in signaling. Consistent
with the preference for IDPs to occupy hub positions, most IDPs rapidly
undergo disorder-to-order transitions upon binding to their biological
target (coupled folding and binding) in order to perform their function
[14]. Thus, conformational dynamics is believed to represent a major
functional advantage for the IDPs, enabling them to interact with a
broad range of biological targets under normal physiological conditions
where their expression is tightly regulated [15,16]. However, experi-
mental evidence demonstrating conformational dynamics in IDPs is
limited to only a few examples [17–25].
Intrinsic disorder also appears to be an important determinant of
dosage-sensitive effects. Thus, IDPs are prone to initiate promiscuous
interactions when overexpressed, suggesting that this is the likely
cause of the resulting toxicity/pathology. Indeed, studies in model
organisms provide compelling evidence supporting this causality [26].
Interestingly, the same properties are strongly associated with dosage-
sensitive oncogenes as well as several other cancer-associated genes
[27] suggesting that mass action driven molecular interactions may
be a frequent cause of cancer [26,28]. In fact, numerous IDPs are also
associated with several other human diseases [11], underscoring the
link between intrinsic protein disorder, promiscuity, and dosage
sensitivity.
The structural ﬂexibility of IDPs could also contribute signiﬁcantly
to ‘noise’ in the PINs especially when IDP expression is dysregulated.
Indeed, recent evidence indicates that the information transduced in
cellular signaling pathways is signiﬁcantly affected by noise [29,30]. In
fact, it has been proposed that noise in these pathways is generated by
the interconnected and promiscuous nature of the PINs and that this
source of noise signiﬁcantly inﬂuences the way signals are transmitted.
Therefore, noisemay be considered an integral part of the correct trans-
mission of signals and signaling cascades including those that play a role
in the ﬁdelity of epigeneticmemory [31].We recently hypothesized that
noise due to IDP conformational dynamics can rewire PINs to cause
phenotypic switching such as the transformation of a normal cell to a
cancer cell [32]. Because noise affects central regulatory switches in
cell functions, it is plausible that alterations in noise level could induce
pathological states such as cancer [31]. It is therefore imperative to
identify proteins that interact with PAGE4.
In this work,we serendipitously identiﬁed the proto-oncogene c-Jun
as a PAGE4 interacting partner. Employing a cell-based reporter system
we demonstrate that PAGE4 interacts with c-Jun and dramatically
potentiates its transactivation. Furthermore, using single-molecule
Förster resonance energy transfer (smFRET) microscopy, we show that
PAGE4 changes conformations upon binding to c-Jun. Taken together,
our results suggest that conformational dynamics may underlie the
observed pleiotropic functions of PAGE4 during prostatic development
and disease.2. Materials and methods
2.1. Yeast two-hybrid screen
Matchmaker Gold yeast two-hybrid screening was performed
according to manufacturer's instruction. Brieﬂy, the cDNA encoding
PAGE4 was inserted in frame into the multiple cloning sites of the
DNA-BD vector, pGBKT7 (Clontech, Mountain View, CA), to generate
the bait plasmid pGBKT7-PAGE4, which was subsequently conﬁrmed
by sequencing. The pGBKT7-PAGE4 plasmid was transformed into the
bait strain Y2HGold. PAGE4 bait strain Y2HGold was mated with the
pre-transformed Y187/pACT2 normalized universal human Mate &
Plate cDNA library according to the Clontech protocol. Diploid yeast
cells were plated on a nutrient deﬁciency medium SD double dropout
plate without Trp and Leu (DDO) and analyzed for their ability to
grow in the presence of highly toxic drug Aureobasidin A (125 ng/ml,
Clontech) and regulate α-galactosidase expression, which hydrolyzes
5-bromo-4-chloro-3-indolyl-a-D-galactopyranoside (X-α-gal, 40 μg/ml,
Clontech, Mountain View, CA) to produce a blue-end product. The se-
lected colonies were restreaked on SD quadruple dropout plate without
Trp, Leu, His and Ade (QDO) containing Aureobasidin A and X-α-gal for
further selection.2.2. DNA expression plasmid constructs
6His-PAGE4 was constructed by cloning the PCR product into
pET28a as in [8]. A18C and P102C 6His-PAGE4 was created in pET28A
via a QuikChange® Site-Directed Mutagenesis Kit (Stratagene, La
Jolla, CA) using 6His-PAGE4 as a template. Cysteine residueswere intro-
duced at the 18th and 102nd position of PAGE4 using the following
primers:
A18C_F:GAGGAAGAGGAGATGGTCAGGAGTGTCCCGATGTGGTTGCAT
TCGTGG C
A18C_R:GCCACGAATGCAACCACATCGGGACAC TCCTGACCATCTCCT
CTTCCTC
P102C_F:GACTAAAGAAGCAGGAGATGGGCAGTGCTAAAAGGGTGGGC
GCGCCGACCC
P102C_R:GGGTCGGCGCGCCCACCCTTTTAGCACTGCCCATCTCCTGCTTC
TTTAGTC.
nV5-PAGE4 was ampliﬁed from 6His-PAGE4 and cloned into the
pcDNA™3.1/nV5-DEST (Invitrogen, Life technologies, Frederick, MD)
according to the manufacturer's instructions. 6myc-ZNF394: ZNF394
cDNA was ampliﬁed from pCMV6-entry-ZNF394 (Origene, Rockville,
MD) using gene speciﬁc primers containing BglII and XhoI sites. It was
cloned into pcS3 + 6myc [33] with an N terminal 6myc tag.2.3. Recombinant protein puriﬁcation
WT/A18C/P102C PAGE4 and c-Jun were cloned into pet28A and
subsequently transformed into BL21DE3pLySs (Invitrogen, Life technol-
ogies, Frederick, MD). Cells were induced with 0.5 mM isopropyl
1-thio-β-D-galactopyranoside (IPTG) for 3 h at 37 °C [34,35]. Recombi-
nant protein was puriﬁed using the ProBond™ Puriﬁcation System
(Invitrogen, Life technologies, Frederick, MD) for purifying His-tagged
proteins using a Nickel-NTA column. Bacterial cell lysates were
prepared using denaturing conditions (6 M guanidine hydrochloride)
and protein was puriﬁed using hybrid conditions (washing the column
with denaturing buffer and subsequently washing with native wash
buffer containing 20 mM imidazole). Eluted protein was concentrated
using polyvinyl pyrollidone (PVP) and dialyzed against 1X Phosphate
Buffered Saline (PBS).
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Protein concentration was estimated using the BCA Protein Assay
Reagent [36] (Thermo Scientiﬁc, Rockford, IL) and 0.5 M Pierce bond-
breaker TCEP solution (Thermo Scientiﬁc, Rockford, IL) was added in a
10× concentration over free cysteines. Dye labeling with either or
both, Alexa Fluor® 555 and Alexa Fluor® 647 (Invitrogen, Life technol-
ogies, Frederick, MD) was carried out by resuspending dyes in 3 μl of
DMSO. Samples were incubated with dye-DMSO for 10 min at room
temperature followed by overnight incubation at 4 °C. The free dye
was further separated from labeled protein using dialysis against 1X
PBS followed bydesaltingusing a SephadexG50 column (SigmaAldrich,
St. Louis, MO).
2.5. Ensemble ﬂuorescence characterization
Ensembleﬂuorescence anisotropywasmeasuredwith aQuantaMaster
40 spectroﬂuorometer (Photon Technology International, Birmingham,
NJ). Alexa555 labeled PAGE4 was measured at 0.5 μM concentration
alone or with 0.04 μg/μl concentration of c-Jun added to the cuvette.
Fluorescence was excited at 532 nm and 5 emission scans from
550 nm to 600 nm were averaged. The peak emission integrated
between 550 nm and 580 nm was used along with instrumental G
factor corrections to calculate anisotropy values reported in the
text [37]. The emission intensities in each of the channels of the
QuantaMaster 40 spectroﬂuorometer were compared to calculate the
ratio of quantum yield of Alexa555 conjugated to PAGE4 at 0.5 μM in
the presence and absence of c-Jun, as described in the text.
2.6. Single molecule FRET studies
Proteinswere immobilized on surfaces of custommade ﬂow cells by
direct immobilization or liposomeencapsulation as described in the text
and in further detail elsewhere [38,39]. Encapsulation used 100 nm
diameter liposomes formed from egg phosphatidylcholine (PC) lipids
doped with 0.1% biotinylated phosphatidylethanolamine (PE) lipids
(both from Avanti Polar Lipids). Fluorescence intensities in donor and
acceptor spectral bands were recorded from immobilized single mole-
cules using a prism-type, total internal reﬂection single molecule
FRET microscope equipped with a Dualview imager (Photometrics)
that has been previously described [40]. The emCCD recorded frames
at 10 Hz, and FRET efﬁciency were calculated from the intensities as
E = Ia/(Ia + Id). γ = 1 was used as a global correction [41] because
analysis of γ from individual molecules with acceptor photobleaching
accompanied with donor recovery yielded gamma values of 0.96, 0.92,
and 0.99 for the A18C/63C mutant as well as 1.13, 1.01, 0.99 for the
P102C/63C where the set of 3 numbers for each mutant reports experi-
ments using PAGE4 with (in order) 1) no addition, 2) full-length c-Jun,
or 3) truncated c-jun. FRET values in the text are reported as the center
value and width of Gaussian ﬁts to histograms assembled by accumulat-
ing all data points from molecules during FRET emitting intervals with
active donor and acceptor dyes for greater than 500 molecules in each
experiment. Supplementary Table 1 includes the values of the centers
and widths of Gaussian ﬁttings for all histograms in this work. We
found that all histograms in thiswork could beﬁttedwith singleGaussian
functions that had widths consistent with expectations for the signal to
noise ratios of our experiments [38,42] except those that included full
length or truncated c-Jun. For those experiments, goodﬁtswere obtained
using sums of twoGaussianswhere the center andwidth of oneGaussian
was ﬁxed those observed in the PAGE4 alone measurements. For double
Gaussian ﬁts, the fraction of events in each of the Gaussian peaks ranged
from 30% to 70% and is listed in detail in Supplementary Table 1. Changes
in peak center greater than 1/4 of the width were deemed as indicating
distinct conformational state because control experiments indicated
that experimental variation of histograms of identical samples is belowthis level. All experiments were in buffer containing 20 mM Tris,
100 mM NaOAc, 5 mMMgCl2 at pH 7.8.
2.7. Luciferase reporter assays
PC3 cells were seeded in a 24 well plate at approximately 20,000
cells/well. Cells were transiently transfected using X-tremeGENE HP
DNA Transfection Reagent (Roche Diagnostics, Indianapolis, IN). The
PathDetect Trans-reporting System (Agilent Technologies, Santa Clara,
CA) was used to test the effect of PAGE4 on c-Jun transactivation using
the manufacturer's instructions. Brieﬂy, reporter plasmid pFR-Luc
(250 ng) was co-transfected with pFA2-c-Jun transactivation plasmid
(12.5 ng) or empty vector pFC2-DBD (12.5 ng) with or without pFC
MEKK (12.5 ng). Different concentrations of nV5-PAGE4 were used to
test dosage effect on c-Jun transactivation. Cells were lysed 48 h after
transfection using Luciferase lysis buffer (25 mM Tris base, 2 mM
EDTA, 10% glycerol, 1% Triton X100. pH adjusted to 7.8 using phosphoric
acid) [43]. Dual-Luciferase® Reporter (DLR™) Assay System reagent
(Promega, Madison, WI) was added to cell lysate and luciferase activity
was recorded on LUMIstar Omega luminescence microplate reader
(BMG Labtech GmbH, Ortenberg, Germany). A similar procedure was
used for the 3′UTR p27 luciferase promoter [44].
2.8. Quantitative real-time PCR
First strand cDNA from pooled normal adult (N = 5) and fetal pros-
tate (N = 1) was obtained from BioChain Institute, Inc. (Newark, CA).
Quantitative real-time PCR (qPCR) reactions were performed with
0.5 μl of cDNA template in 25 μl of reaction mixture containing 12.5 μl
of iQ SYBR Green Supermix (Bio-Rad Laboratories, Inc., Hercules, CA)
and 0.25 μmol/l each primer. PCR reactions were subjected to hot start
at 95 °C for 3 min followed by 45 cycles of denaturation at 95 °C for
10 s, annealing at 60 °C for 30 s, and extension at 72 °C for 30 s using
the CFX96 Real-Time PCR Detection System (Bio-Rad Laboratories, Inc.).
PCR primers were 5′- CGTAAAGTAGAAGGTGATTG -3′ (forward) and
5′- ATGCTTAGGATTAGGTGGAG -3′ (reverse) for PAGE4, 5′- TAACAGT
GGGTGCCAACTCA -3′ (forward) and 5′- TTTTTCTCTCCGTCGCAACT -3′
(reverse) for c-Jun and 5′- GAATATAATCCCAAGC GGTTTG -3′ (forward)
and 5′- ACTTCACATCACAGCTCCCC -3′ (reverse) for TATA binding protein
(TBP)[45]. Analysis and fold differences were determined using the com-
parative threshold cycle method. All experiments were performed in
triplicate and data presented represents mean ± SD. Data are presented
as mean ± SD and statistical differences between two groups of data
were analyzed using the Student's t test. Statistical signiﬁcance was
applied to P values of less than 0.05.
2.9. Immunohistochemistry
Thepolyclonal PAGE4antibodyWER2was generated asdescribedpre-
viously [46] using the following peptide N-CKTPPNPKHAKTKEAGDGQP-
C (Sigma-Gneosys). Immunohistochemical (IHC) staining was con-
ducted using an EnVision™ FLEX System (Dako) according to the
manufacturer's protocol with minor modiﬁcations. The parafﬁn section
was blocked in 5% skimmilk for 1 h and then treated withWER2 rabbit
polyclonal antibody that was diluted at 1:1000 for 30 min at room
temperature.
3. Results
3.1. Both PAGE4 and c-Jun are overexpressed in the developing prostate
While there is good evidence in the literature supporting upregula-
tion of both PAGE4 and c-Jun in the diseased prostate, not much is
known about their co-expression in the developing gland. Therefore,
we determined the relative expression of both genes at the mRNA
level in the same human fetal prostate samples by qPCR. As shown in
12 wks 21 wks 36 wks
A B
C D E
Fig. 1. PAGE4 and c-Jun expression in normal adult and fetal prostate. Messenger RNA levels of PAGE4 (A) and c-Jun (B) were determined in normal adult and fetal prostate by qPCR.
Human fetal cDNA was purchased commercially. PAGE4 and c-Jun mRNA expression was normalized to TATA binding protein (TBP). The experiments were repeated three times. Data
are represented as mean of triplicate experiments ± SD. (*P b 0.01, Student's t test). (C–E) Fetal prostate was stained for PAGE4 at gestational weeks 12, 21 and 36.
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developing prostate when compared to the normal adult prostate. To
determine expression at the protein level, parafﬁn-embedded sections
of human fetal prostate tissue obtained from various gestational stages
were stained with a PAGE4-speciﬁc antibody. As shown in Fig. 1C–E,
while the PAGE4 protein is highly expressed in the earlier stages of
fetal development, its expression decreases dramatically by the time
the pre-pubertal prostate buds are developed (36 weeks). Taken
together, the data highlight its potential role in the development of
this sex gland.
3.2. Biophysical characterization of the PAGE4 protein
We had previously provided preliminary evidence using a combina-
tion of gel electrophoresis, size exclusion chromatography (SEC), circu-
lar dichroism (CD) and one dimensional nuclear magnetic resonance
(NMR) spectroscopy conﬁrming bioinformatic predictions that PAGE4
is intrinsically disordered [8]. Here, we quantify the SEC results for com-
parisonwith dynamic light scattering (DLS) and smFRETmeasurements
to gain additional insight into its ensemble characteristics at the single
molecule level.
The SEC results were calibrated against measurements of ovalbumin
(MW43 kD; elution 15.6 ml) and ribonuclease A (MW13.7 kD; elution
18.3 ml). The hydrodynamic radii (Rh) for these standardswere derived
from published relationships between Rh and molecular weights
for globular proteins [47] and deﬁned as log(Rh) = −0.204 +
0.357log(MW) with MW in Daltons and Rh in Angstroms. A linear ﬁt
of log (Rh) versus the elution volume (Ve) for the standards, log(Rh) =
2.4748–0.65681*Ve, was used to determine Rh for PAGE4 from its
elution volume. The SEC of PAGE4 produced 2 peaks at 14.2 ml and
15.7 ml, suggesting Rh of 3.5 and 2.8 nm. DLS measurements using aMalvern Nanosizer of PAGE4 yielded an Rh = 3.2 ± 0.2 nm (average ±
1 standard deviation of 3 independent repeated experiments), which is
consistent with the Rh measurement using SEC. The large Rh size deter-
mined from both SEC and DLS for a protein as small as PAGE4 (only 102
amino acids, 11.15 kDa) is good evidence of the molecule being highly
intrinsically disordered. Using published relationships between Rh and
molecular weights for disordered proteins in various structural forms
[47], Rh is expected to be 1.7 nm if folded globular, 2.8 nm if native
unfolded coil-like, and 2.5 nm if native unfolded pre-molten globule.
There is good agreement between measured SEC and expected coil-
like Rh for disordered PAGE4. The second SEC elution peak is possibly a
larger, dimeric PAGE4 form. Themeasured Rh is close to the 3.3 nm pre-
dicted size for the disordered pre-molten globule form of a PAGE4 dimer
[47], suggesting that partial compaction may accompany dimerization.
Next, to further examine speciﬁc conformational properties of the
intrinsic disorder of PAGE4, we developed a smFRET assay. A unique
advantage of smFRET is that it can capture information normally lost
through ensemble averaging of heterogeneous and dynamic samples.
Furthermore, immobilization of single molecules under conditions
that retain their biological activity, allows for extended observation of
the same molecule for tens of seconds, facilitating the capture of slow
conformational transitions or protein binding and unbinding cycles.
Finally, the use of an open geometry for immobilization permits direct
observation of the response to changing solution conditions or adding
ligands.
We generated 2 different cysteine (Cys)mutants of PAGE4 thatwere
labeledwith donor and acceptor ﬂuorophores for FRET studies. Cysteine
residues were introduced near the N terminus or C terminus of the 102
amino acid long PAGE4 molecule at positions 18 or 102 by replacing an
Ala (A18C) and Pro (P102C) residue, respectively. These mutants alter-
nately combined with the single native Cys residue at position 63 to
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labeled with Alexa Fluor 555 (AF555, FRET donor) and Alexa Fluor 647
(AF647, FRET acceptor) resulting in random attachment of donor and
acceptor on the cysteines. Proteinmolecules emitting ﬂuorescence indi-
cating that exactly 1 donor and 1 acceptorwere isolated for further anal-
ysis. The mutant PAGE4 polypeptides were labeled efﬁciently with the
donor/acceptor dyes and the labeled samples ran as a single band of
the expected molecular weight in SDS-PAGE analysis (Supplementary
Fig. 1).
We immobilized the PAGE4 FRET mutants on a surface to allow
extended smFRET measurements. Widely spaced streptavidin mole-
cules were deposited on quartz slides and the intervening spaces were
passivated by lipid bilayers [48]. Next, biotinylated antibodies to 6His
tags (Thermo Scientiﬁc Cat #: MA1-80087) were bound on the surface
adhered streptavidin. Finally, PAGE4was immobilized on the antibodies
via its N-terminal 6His tag. Singlemolecule FRET signals weremeasured
from these surface tethered PAGE4 samples (seeMethods). Time trajec-
tories of donor and acceptor emission intensities (Id and Ia respectively)
from individual molecules were steady until single step photobleaching
events (Fig. 2) that conﬁrmed singlemolecule detection. FRET efﬁciency
calculated from the intensities as E = Ia/(Ia + Id) and FRET ratio histo-
grams made from E for many molecules were consistent with rapid
motion of the donor and acceptor attachment locations around Root
Mean Square (RMS) distances as expected for IDPs. In particular, the
widths of the histograms were shot noise limited indicating themotion
wasmuch faster than that of the 100millisecond sampling time. To test
for possible undesirable interactions with the surface we compared
FRET measurements of PAGE4 directly tethered to the surface coated
with 6His antibodies to FRET measurements of PAGE4 encapsulated
inside 100 nm diameter liposomes, which were tethered to the surface
[38,49]. Gaussian ﬁts (center ± sigma) to the histograms were nearly
unchanged for direct immobilization and liposome encapsulated for
both A18C/63C (direct E = 0.56 ± 0.17; encapsulated E = 0.55 ±
0.17) and P102/63C (direct E = 0.65 ±0.18; encapsulated E = 0.65 ±
0.17) mutants. Of particular note, in contrast to some other IDPs [38],
no slow conformational switching was observed in PAGE4 (Fig. 2C–F).
We used these FRET measurements to estimate a scale characteriz-
ing the size of disordered PAGE4. For conversion of measured FRETFig. 2. Singlemolecule FRET indicates that PAGE4 is an intrinsically disordered protein. (A) Sche
(red). Single PAGE4 proteinmoleculeswere encapsulated inside 100 nmdiameter liposomes tet
Fluorescence emission timecourses in the donor and acceptor spectral bandswere collected and
timecourses showing anti-correlated donor/acceptor behavior upon photobleaching, which is c
mutants. The color bar at the top indicates the illumination color. Red illumination at the start
acceptor. The disappearance of red emission (with anticorrelated recovery of green) is photoblea
Histograms assembled from all FRET active data points of over 300molecules are shown for A18
based upon modeling PAGE4 as a highly ﬂexible IDP.efﬁciency into distance, we determined that the γ factor was 0.96 for
the A18C/63C mutant and 1.13 for the P102C/63C. Therefore, we used
γ = 1 as a global correction [41] and a Förster radius of 5.24, which is
a value used in the literature for this dye pair [50]. As described else-
where, we used a Gaussian probability distribution for the RMS distance
between the cysteines used for dye attachment to recover the RRMS
from the experimentally determined dye separations from FRET [38].
This analysis yielded RRMS = 5.52 nm for A18C/63C FRET and RRMS =
4.95 nm for P102C/63C FRET. Using 0.36 nm per amino acid, we deter-
mined the contour length of the protein chain between the dye-labeled
cysteines to be 16.2 nm (A18C/63C) and 14.04 nm (P102C/63C).
Themeasured RRMS and contour length between the donor and acceptor
attachment sites can be used with the random polymer model
(RRMS2 = 2lpL) [51,52] to determine the persistence length (lp) of the
intervening protein as 0.94 nm (A18C/63C) and 0.87 nm (P102C/63C).
The expected RRMS for the whole protein is then estimated to be
8.3 nm or 8.0 nm by using the A18C/63C or P102C/63C lp values with
the 36.7 nm contour length of the full-length protein of 102 amino
acids. Radius of gyration (RG) estimates derived from RRMS (RG =
RRMS/√6) are 3.39 and 3.27 nm for A18C/63C and P102C/63C, respec-
tively. The radius of gyration estimates allows 4 comparisons of the
ratios of gyration radius to hydrodynamic radius (RG/Rh) using Rh
from gel ﬁltration (2.8 nm) and DLS (3.2 nm). These are 1.21, 1.17,
1.06 and 1.02 (average 1.12, SD 0.09). The average of these values com-
pares well with a study of an array of chemically denatured proteins
where the average RG/Rh = 1.06 was found [53]. These comparisons
of smFRET derived characterizations with hydrodynamic characteriza-
tions further conﬁrm that PAGE4 is a highly disordered protein.
3.3. Identifying PAGE4 interacting partners
Although the smFRET results indicated lack of stochastic conforma-
tional ﬂuctuations, it is plausible that the PAGE4molecule switches con-
formations upon interacting with a biological target (coupled folding
and binding). Therefore, we next focused on identifying protein part-
ners that may interact with PAGE4 so that they could be used as ligands
in the smFRET assay. To this end we employed the yeast two hybrid
system as described in the Materials & Methods. Brieﬂy, the PAGE4matic of the PAGE4 constructs with the native cysteine (green) and the introduced cysteine
hered to a quartz surface. (B) Shows a cartoon of this immobilization scheme (not to scale).
those indicating exactly 1 donor and 1 acceptor were further analyzed. Example intensity
haracteristic of single molecules, are shown for the A18C/63C (C) and P102C/63C (E) FRET
driving only acceptor ﬂuorescence allows identiﬁcation of molecules containing an active
ching of the acceptor, and disappearance of green emission is photobleaching of thedonor.
C/63C (D) and P102C/63C (F) PAGE4mutants. These FRET signals agree with expectations
159K. Rajagopalan et al. / Biochimica et Biophysica Acta 1842 (2014) 154–163molecule fused in frame to the GAL4 DNA binding domain (GAL4-DBD)
served as the bait and a PCa cDNA library fused in frame to the GAL4
activation domain (GAL4-AD) as the prey. This screen resulted in
several colonies on double dropout (Leu−, Trp−) plates but only one
colony was positive when plated on quadruple dropout (Leu−, Trp−,
Ade−, His−) plates containing X-α-gal (Supplemental Fig. 2) suggesting
that this clone represents a putative PAGE4 interacting partner.
Sequencing of the plasmid insert from the quadruple positive clone
showed that this plasmid contained the cDNA encoding the human
ZNF394 sequence.
ZNF394 is a 64 kDa zinc ﬁnger protein that is speciﬁcally expressed
in the heart, skeletal muscle, and brain in adult human tissues [54].
Overexpression of ZNF394 in COS-7 cells inhibits the transcriptional
activities of c-Jun and AP-1 reporters, suggesting that ZNF394 is a tran-
scriptional repressor in theMAP kinase signaling pathway andmay play
an important role in cardiac development and/or cardiac function. To
conﬁrm the yeast two hybrid data, we set up the c-Jun/AP-1 reporter
system in the PC3 PCa cell line. As shown in Supplemental Fig. 3,
GAL4-c-Jun in the presence of MEKK, showed a robust activation of
the reporter gene. But in contrast to the results of Huang et al. in
COS-7 cells [54], ZNF394 did not repress c-Jun activity in PC3 cells. Sur-
prisingly, however, the addition of PAGE4 further enhanced the activity
of c-Jun suggesting that PAGE4may directly interact with c-Jun instead.3.4. PAGE4 potentiates transactivation of the proto-oncogene c-Jun
To test the effect of PAGE4 on c-Jun transactivation, we used a
reporter gene assay. We titrated various concentrations of nV5-PAGE4
with DNA-binding domain (DBD) of the yeast protein GAL4 (aa1-147)
fused in-frame to the transactivation domain of c-Jun (aa 1-223) in
PC3 cells. As shown in Fig. 3, the results clearly indicate that PAGE4
potentiates c-Jun transactivation in a dosage-dependent manner. To test
the overall effect on the activation of JNK pathway, we co-expressed the
kinase domain of human MEKK protein (aa 380-672) in the presence
of different concentrations of PAGE4. MEKK is a Serine/Threonine-
speciﬁc MAPKKK that activates JNK pathway [55]. MEKK along with
JNKK activate JNKwhich phosphorylates and transcriptionally activates
c-Jun [56]. Interestingly, in the presence of MEKK and PAGE4, luciferasenV5-PAGE4(ng)
Gal4-c-JUN
MEKK
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Fig. 3. PAGE4 potentiates the c-Jun activity. GAL4 (aa 1-147) or GAL4-cJUN (aa 1-223) was cotr
into PC3 cells. The V5 epitope tag is a small epitope (GKPIPNPLLGLDST) that is derived from th
terminus. Luciferase activities from a GAL4 binding site-driven reporter construct were measuactivity was increased by ~600 fold as compared to empty vector/
control as shown in Fig. 3. Therefore, we conclude that PAGE4 potenti-
ates c-Jun transactivation in aMEKK-JNK-dependentmanner. However,
a PAGE4 GAL4 fusion construct failed to transactivate the luciferase
reporter gene (not shown). These data strongly suggest but do not
necessarily prove that PAGE4 directly interacts with c-Jun but by itself
is not a bona ﬁde transcription factor.3.5. c-Jun induces conformational changes in PAGE4 upon binding
We used smFRET to further characterize the c-Jun interaction with
PAGE4. To this end, the FRET reporting donor/acceptor labeled PAGE4
double cysteine mutants were immobilized on a surface through bind-
ing of the N-terminal 6His tag to a biotinylated 6His antibody attached
to streptavidin on the surface (Fig. 4A).
The FRET values from PAGE4 changed substantially upon addition of
40 μg/ml (1.6 μM) of a commercially obtained, bacterially expressed
fragment of truncated c-Jun (aa 1-241; ProSpec, catalog number PKA-
001). FRET from the N-terminal label pair A18C/63C shifted higher
while FRET from the C-terminal P102C/63C mutant shifted lower
(Fig. 4) indicating interaction between c-Jun and PAGE4. We ﬁt the
FRET histograms with sums of 2 Gaussians where one Gaussian
matched the free PAGE4 experiment to account for partial saturation
of the c-Jun/PAGE4 interaction. The new Gaussians that emerged had
widths consistent with expectations due to experimental conditions
(Methods and Supplementary Table 1) and had centers that were
shifted from the free PAGE4 value by more than the typical run to run
variation of control experiments (A18C/63C: 0.56 without c-Jun, 0.61
with c-Jun; P102C/63C: 0.65without c-Jun, 0.39 with c-Jun), suggesting
a distinct conformational state. To discern the contribution of the
c-terminal domain of the c-Jun molecule that comprises the DNA-
binding and dimerization domains (the basic leucine zipper region) in
the interaction with PAGE4, bacterially expressed and puriﬁed full-
length c-Jun protein was added at the same concentration. The new
FRET peak for both truncated and full-length c-Jun consistently shifts
in FRET values from free PAGE4 FRET peaks (A18C/63C: 0.56 without
c-Jun, 0.62 truncated c-Jun, 0.80 full length c-Jun; P102C/63C: 0.65
without c-Jun, 0.39 truncated c-Jun, 0.37 full length c-Jun) (Fig. 4C &12 25 50 100 0 6 12 25 50 100
- - - -
+ + + + + + + + + +
+ + + + + +
- - - - - - - - - -
ansfected with or without MEKK and various amounts of V5-tagged PAGE4 (nV5-PAGE4)
e P and V proteins of the paramyxovirus of simian virus 5 and was fused in-frame at the N
red and plotted with reference value normalized to 1.
Fig. 4. Single molecule FRET indicates interaction with c-Jun alters the conformation of PAGE4. Alexa555/Alexa647 labeled PAGE4 containing a 6His tag was directly immobilized on a
quartz surface with widely spaced streptavidin molecules adhered, which were used to link to biotinylated-6-His-antibodies. The space between streptavidins was passivated with a
lipid bilayer. (A) Displays a cartoon of this immobilization scheme (not to scale). Singlemolecule ﬂuorescence time traces for donor and acceptor emission were analyzed frommolecules
conﬁrmed to contain exactly 1 donor and 1 acceptor for the A18C/63C (panel B) and P102C/63C (panel D) FRET mutants in the absence of c-Jun. The color bar at the top indicates the
illumination color. Histograms assembled from all FRET active data points of over 300 molecules are shown as the red curves for A18C/63C (panel C) and P102C/63C (panel E) PAGE4
mutants. Note FRET measurements of liposome encapsulated PAGE4 (Fig. 2) agree with the FRET measured from this directly surface immobilized PAGE4. The blue curves are FRET
histograms from PAGE4 in the presence of 0.4 mg/ml truncated c-Jun for the A18C/63C (panel C) and P102C/63C (panel E) PAGE4 mutants. C-Jun causes FRET to increase for A18C/
63C mutant and to decrease for P102C/63C mutant. The green curves in C and E are for full-length c-Jun.
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FRET for PAGE4 A18C/63C and consistent decreases in FRET for PAGE4
P102C/63C, suggesting that interaction of PAGE4with c-Jun ismediated
via the proximal portion of the molecule that harbors the
transactivation domain [57].
To rule out potential experimental artifacts due to crowding or
non-speciﬁc binding, we measured smFRET after including 100 μg/ml
of bovine serum albumin (BSA) with PAGE4. However, this caused no
change in FRET in either mutant (Fig. 5, with BSA) ruling out simple
non-speciﬁc crowding as causing FRET changes. To interrogate for
possible interactions directly with the ﬂuorophores, we measuredFig. 5. Crowding and lipid interactions do not alter PAGE4 conformation. Histograms of
single molecule FRET signals from surface immobilized PAGE4 (gray bars) are unchanged
from single molecule FRET histograms of surface immobilized PAGE4 in the presence of
0.1 mg/ml bovine serum albumin (red curve) or 20% cardiolipin containing PC liposomes
(blue curve) for both the P102C/63C (A) and A18C/63C (B) PAGE4 mutants.effects of c-Jun on ﬂuorescence anisotropy and quantum yield (QY) of
Alexa 555 attached to PAGE4. Fluorescence anisotropy measurements
conﬁrmed that c-Jun did not dramatically alter dye mobility. The ﬂuo-
rescence anisotropy of PAGE4 labeled with only Alexa 555 did not
change for either wild type protein containing only the native centrally
located cysteine (0.248 without c-Jun, 0.242 with c-Jun) or the double
cysteine mutants (with very low labeling efﬁciency so that nearly all
molecules only contain one Alexa 555 randomly distributed between
the cysteine) A18C/63C (0.257 without c-Jun, 0.250 with c-Jun) and
P102C/63C (0.244 without c-Jun, 0.250with c-Jun). In contrast, interac-
tionswith c-Jun caused changes in the quantum yield (QY) of Alexa 555
attached to all cysteines used in our studies. The ratio of QY after adding
full-length c-Jun to QY before adding c-Jun was 1.24 (WT), 1.27 (A18C/
63C) and 1.38 (P102C/63C). The FRET γ-factor, which is sensitive to the
ratio of acceptor QY to donor QY, changed from +3% to −12% upon
c-Jun exposure for the various experimental permutations (Methods).
In combination, the change in donor QY and FRET γ-factor suggests
that the acceptor QY also changes on the order of 10% upon c-Jun
binding.
Changes in donor QY in the absence of conformational change will
cause FRET efﬁciency to change because the Förster radius parameter
depends on the 1/6 power of the donor QY. Consideration of how
donor QY affects FRET demonstrates this phenomenon is not causing
the FRET change we observe in our experiment. Neglecting the coinci-
dent change inγ-factor (that shifts FRET efﬁciency in the opposite direc-
tion from the effect we are considering due to changing donor QY
altering the Förster radius parameter), it may be shown that upon a
change in donor QY fromΦdonor, old toΦdonor, new the change in FRET ef-
ﬁciency from Eold to Enew is
Enew ¼ 1= 1þ Φdonor;old=Φdonor;new
 
 1=Eoldð Þ−1ð Þ
n o
:
Using (Φdonor, new/Φdonor, old) = 1.2 (which is the scale of QY change
we measured), this analysis predicts the expected changes in FRET
efﬁciency for A18C/63C is +0.0443 and for P102C/63C is +0.0403.
We observed change in FRET of −0.15 (A18C/63C) and +0.27
(P102C/63C). The much larger changes in FRET than expected from
Fig. 6. PAGE4 expression causes down-regulation of p27 in PC3 cells. A luciferase reporter
assay was conducted with either wild type (wt) or mutant (mut) p27 3′UTR fused to
luciferase. The mut vector had the mir221/222 binding sites scrambled. The assay was
done in quadruplicate and the empty vector was normalized to 100%.
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and anisotropy results provide strong support to the interpretation
that c-Jun substantially alters the global conﬁguration of PAGE4. More
intuitively, it can be simply stated that increases in donorQY aswemea-
sured for both labeled constructswill increasemeasured FRET efﬁciency
whenﬂuorophore separation does not change. In our experiments, FRET
increases for the P102/63C construct but decreases for A18C/63C con-
struct, which is only possible if c-Jun causes conformational changes
in PAGE4.
We also explored an additional line of evidence to demonstrate
speciﬁcity. Upon exposing PCa cell lines to stressful conditions such as
nutrient deprivation for example, there is a signiﬁcant increase in
mitochondrial-associated PAGE4 and a concomitant decrease in cyto-
plasmic levels of PAGE4 (Zeng et al., unpublished). In a recent publica-
tion, Zigoneanu et al. [58] observed that the IDP α-synuclein interacts
strongly with large unilamellar vesicles whose composition is similar
to that of the innermitochondrialmembrane,which contains cardiolipin.
Therefore, to test for possible interactions between cardiolipin and
PAGE4, we encapsulated the donor/acceptor labeled PAGE4 constructs
inside liposomes consisting of 80%PC/20% cardiolipin. As shown in
Fig. 5A and B, we measured FRET signals from both the A18C/63C and
P102C/63C donor/acceptor labeled FRET mutants of PAGE4 inside 20%
cardiolipin liposomes that were unchanged from surface tethered or
100% PC liposome encapsulated experiments. Collectively, these data
suggest that although PAGE4 relocalizes to the mitochondrion under
stress, it does not interact with cardiolipin in the mitochondrial inner
membrane, or if it does, cardiolipin does not induce substantial confor-
mational changes in PAGE4. These observations underscore the signiﬁ-
cance of PAGE4 interactions with c-Jun.
3.6. PAGE4 modulates expression of the c-Jun targets mir221/222 that
target p27 in prostate cancer
MicroRNAs (miRNAs) are potent negative regulators of gene expres-
sion and are frequently implicated in many types of cancer including
PCa. While some miRNAs are upregulated and thought to function as
oncogenic, others that are downregulated are believed to act as tumor
suppressors. Mir-221 and miR-222 are two closely related miRNAs
that are encoded in cluster from a genomic region on chromosome X
and are strongly upregulated in many cancers where they were
shown to play an oncogenic role via the downregulation of several
tumor suppressors such as p27, p57, PTEN and many others [59,60].
The expression of these miRNAs in PCa cells is thought to be driven by
the cooperative interaction of NFkB and c-Jun on two separate distal
regions upstream of miR-221/222 promoter [61]. Therefore, we
reasoned that if PAGE4 potentiates c-Jun transactivation, one would
observe an increase in the down regulation of the mir221/222 targets.
To test this possibility, we conducted a luciferase reporter assay in PC3
cells with the wild type or mutant p27 3′UTR in which the mir221/
222 binding sites were scrambled and fused to the luciferase reporter.
As shown in Fig. 6, overexpressing PAGE4 resulted in ~50% decrease in
the reporter activity; however, ~10% decrease was observed with the
mutant reporter suggesting that in PCa cells, PAGE4 by potentiating
c-Jun transactivation contributes to tumorigenesis by downregulating
tumor suppressors such as p27.
4. Discussion
Considered together, our results demonstrating that PAGE4 interacts
with c-Jun to potentiate its transactivation, and that this interaction
induces conformational changes in PAGE4, have signiﬁcant implica-
tions. From a fundamental perspective, recent research on IDPs and
how they might contribute to pathological states when overexpressed
suggests that noise in PINs contributed by the conformational dynamics
of IDPs plays a critical role in information transfer in cancer[32]. Since
many IDPs transition from disorder to order upon binding to theirtarget, stochasticity of IDP interactions allows the system to search
through numerous iterations of network interactions and select those
that increase ﬁtness. Rewiring of noise-driven PINs can activate latent
pathways that drive cellular transformation and adaptation [32]. Thus,
given the potential for conformational ﬂexibility, PAGE4 could rewire
PINs by interacting with multiple partners and drive cellular transfor-
mation. It is noteworthy that to date, no activating mutations have
been reported for any of the bona ﬁde CTAs, a majority of which are
IDPs [7] and are overexpressed in several types of cancer.
Fromamedical perspective, several lines of evidence have illustrated
the importance of c-Jun overexpression in both benign prostatic hyper-
plasia (BPH) and PCa. First, c-Jun is a coactivator of the androgen recep-
tor (AR) [62–64], a key player in both BPH [65]as well as PCa [62,66].
c-Jun stimulates AR transactivation by mediating receptor dimerization
and subsequent DNA binding [63]. Interestingly, c-Jun also enhances AR
transactivation in androgen-independent PCa cells, which closelymimic
hormone-refractory PCa cells in gene expression and growth behavior
[66]. Furthermore, repression of endogenous c-Jun expression results
in markedly reduced growth of these cells, strongly suggesting an
important biological role for c-Jun in hormone-refractory PCa. Second,
c-Jun, by acting on the distal enhancer region, cooperates with other
factors to induce expression of the oncogenic microRNAs miR-221/222
[67]. Mir-221 and miR-222, two closely related microRNAs encoded in
a cluster from a genomic region on chromosome X, are strongly upreg-
ulated in several forms of human tumors including PCa [67]. Third, like
PAGE4, c-Jun is also expressed in BPH, underscoring the functional
signiﬁcance of the PAGE4/c-Jun interaction. The c-Jun protein in pros-
tate ﬁbroblasts regulates production and paracrine signals of insulin-
like growth factor-1 (IGF-1)which stimulate BPH-1 cellular proliferation.
In addition, stromally produced IGF-1 upregulates epithelial mitogen-
activated protein kinase, Akt, and cyclin D1 protein levels while down-
regulating the cyclin-dependent kinase inhibitor p27. Together these
data suggest that stromally expressed c-Jun may promote prostatic
epithelial proliferation through IGF-1 as a paracrine signal that, in
turn, can promote prostate epithelial proliferation [65]. Finally, the
role of c-Fos and c-Jun in PCa progression and recurrence has been
elegantly demonstrated both in transgenic mouse models as well as in
human PCa. Thus, forced expression of c-Fos and c-Jun in PCa cells
promotes tumorigenicity and results in activation of an extracellular
signal-regulated kinase signaling. Additionally, up-regulation of both
c-Fos and c-Jun proteins occurs in advanced disease is correlated with
extracellular signal-regulated kinase pathway activation [68]. Taken
162 K. Rajagopalan et al. / Biochimica et Biophysica Acta 1842 (2014) 154–163together, our ﬁndings that PAGE4 interacts with c-Jun, which is an
important player in human PCa, and potentiates its transactivation
reveal a hitherto unappreciated role for this CTA in PCa.
It is important to note that c-Jun typically heterodimerizes with
c-Fos, and together they constitute a member of the AP-1 family of
transcription factors [69,70]. Thus, it will be important to determine
whether PAGE4 interacts with c-Jun alone or with the Jun/Fos heterodi-
mer and how this interaction could affect its ability to potentiate AP-1
transactivation. Nonetheless, the present study suggests that disrupting
PAGE4/c-Jun interactions using small molecules may serve as a promis-
ing therapeutic opportunity for BPH aswell as PCawhich are among the
most common ailments in the aging male population worldwide.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2013.11.014.
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